DVT Prophylaxis in Outpatient Leg Fracture
For outpatients with leg fractures, prescribe pharmacologic thromboprophylaxis with low molecular weight heparin (LMWH) or enoxaparin for patients who cannot bear weight (less than 20 kg) or have limited ankle mobility (less than 20 degrees), while patients achieving near-physiological activity levels may not require pharmacologic prophylaxis.
Risk Stratification Algorithm
The decision to use pharmacologic prophylaxis hinges on functional mobility assessment:
High-risk patients requiring prophylaxis:
- Unable to bear weight ≥20 kg on affected limb
- Ankle range of motion <20 degrees
- Additional VTE risk factors (obesity, prior VTE, active cancer, prolonged immobilization)
Low-risk patients who may not require prophylaxis:
- Able to bear weight ≥20 kg
- Ankle mobility ≥20 degrees
- No additional VTE risk factors
- Compliant with mobilization instructions
This stratification is supported by prospective data showing zero thromboembolic complications in outpatients achieving physiological activity levels without prophylaxis, compared to 4% DVT rate in immobilized patients receiving prophylaxis 1.
Pharmacologic Agent Selection
LMWH (enoxaparin) is the preferred agent over unfractionated heparin due to superior safety profile, with studies demonstrating 87.5% complication-free outcomes, 7.9% DVT rate, and only 5% hemorrhagic complications compared to 42.9% hemorrhagic complications with standard heparin 2.
Aspirin is NOT recommended as monotherapy for outpatient leg fracture prophylaxis. Recent meta-analysis data show aspirin increases deep vein thrombosis risk by 48% compared to enoxaparin (RR=1.48,95% CI 1.16-1.89) 3. While aspirin shows no difference in pulmonary embolism or mortality, the higher DVT rate makes it inappropriate as first-line prophylaxis, particularly since most aspirin trials excluded high-risk trauma patients 4.
Treatment Duration
Continue prophylaxis until the patient achieves functional mobility criteria (weight-bearing ≥20 kg and ankle mobility ≥20 degrees). Score-based assessment reduces DVT incidence from 10% to 4% when properly applied 5.
Critical Pitfalls
- Do not rely on aspirin alone despite recent orthopedic trauma literature suggesting equivalence—these studies excluded high-risk patients and showed higher asymptomatic DVT rates 6, 4
- Patient non-compliance is the primary cause of prophylaxis failure—the two DVT cases in low-risk groups occurred in non-compliant patients 1
- Reassess risk daily—transition patients off prophylaxis once mobility criteria are met rather than using arbitrary time-based protocols
Special Considerations
For patients with active cancer and leg fractures, oral factor Xa inhibitors (apixaban, edoxaban, rivaroxaban) are preferred over LMWH per current VTE guidelines 7, though this applies to established VTE rather than primary prophylaxis in trauma.
The evidence strongly supports functional assessment-driven prophylaxis rather than blanket treatment of all outpatient leg fractures, balancing thrombotic risk against bleeding complications while optimizing cost-effectiveness.